We are live on ! Find out more
Bleichroeder

Bleichroeder Portfolio holdings

AUM $1.02B Turnover 33.63%
1-Year Est. Return 33%
This Fund
S&P 500
This Quarter Est. Return
-1.54%
1 Year Est. Return
+33%
3 Year Est. Return
+222.49%
5 Year Est. Return
+219.92%
10 Year Est. Return
–
AUM
$479M
AUM Growth
-$5.04M
Cap. Flow
+$8.34M
Cap. Flow %
1.74%
Top 10 Hldgs %
67.05%
Holding
98
New
1
Increased
4
Reduced
1
Closed
5
Avg Time Held
1.7 years
Top 10 Avg Time Held
1.5 years
Top 20 Avg Time Held
1.6 years

Top Buys

Rank Stock Value
1
PROK icon
ProKidney
PROK
+$17.4M
2
GPGI icon
GPGI Inc
GPGI
+$3.2M
3
TCDA
Tricida, Inc. Common Stock
TCDA
+$547K
4
ONDS icon
Ondas Inc
ONDS
+$436K
5
LIQT icon
LiqTech
LIQT
+$267K

Sector Composition

Rank Sector Weight
1 Healthcare 23.49%
2 Consumer Discretionary 16.65%
3 Miscellaneous 15.6%
4 Industrials 15.31%
5 Financials 13.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
GLD icon
1
SPDR Gold Trust
GLD
$130B
$73.5M 15.33%
475,000
– –
2019 Q4
11 quarters
BC icon
2
Brunswick
BC
$4.89B
$63.9M 13.32%
975,636
– –
2020 Q1
10 quarters
LIN icon
3
Linde
LIN
$242B
$34.7M 7.23%
128,564
– –
2019 Q4
11 quarters
INVE icon
4
INVE Technologies, Inc. Common Stock
INVE
$64.5M
$33M 6.89%
2,634,495
– –
2019 Q4
11 quarters
IVAC icon
5
DELISTED
Intevac Inc
IVAC
$23M 4.8%
4,944,105
– –
2019 Q4
11 quarters
CTIC
6
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$23M 4.79%
3,943,730
-5,000
-0.1% -$31.2K
2021 Q4
3 quarters
PACX
7
DELISTED
Pioneer Merger Corp. Class A Ordinary Share
PACX
$21.2M 4.42%
2,125,000
– –
2021 Q2
5 quarters
PROK icon
8
ProKidney
PROK
$218M
$18M 3.76%
+2,000,000
New +$17.4M
2022 Q3
0 quarters
THO icon
9
Thor Industries
THO
$3.99B
$15.9M 3.32%
227,500
– –
2020 Q1
10 quarters
DRRX icon
10
DELISTED
DURECT Corp
DRRX
$15.3M 3.19%
2,641,466
– –
2019 Q4
11 quarters
GPGI icon
11
GPGI Inc
GPGI
$4.04B
$14.7M 3.07%
3,531,746
+681,891
+24% +$3.2M
2022 Q1
2 quarters
OPTN icon
12
DELISTED
OptiNose
OPTN
$13.8M 2.89%
252,132
– –
2021 Q4
3 quarters
MDXH icon
13
MDxHealth
MDXH
$13.7M
$13.2M 2.76%
1,958,333
– –
2021 Q4
3 quarters
CORS
14
DELISTED
Corsair Partnering Corporation
CORS
$12.2M 2.55%
1,250,000
– –
2021 Q3
4 quarters
SPGI icon
15
S&P Global
SPGI
$137B
$12.2M 2.55%
40,000
– –
2019 Q4
11 quarters
LSXMK icon
16
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
$8.91M 1.86%
305,187
– –
2019 Q4
11 quarters
MRNS icon
17
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$8.79M 1.83%
1,322,463
– –
2020 Q1
10 quarters
BX icon
18
Blackstone
BX
$95B
$6.7M 1.4%
80,000
– –
2019 Q4
11 quarters
TV icon
19
Televisa
TV
$2.35B
$5.38M 1.12%
1,000,000
– –
2021 Q2
5 quarters
TCDA
20
DELISTED
Tricida, Inc. Common Stock
TCDA
$5.24M 1.09%
500,000
+50,000
+11% +$547K
2021 Q3
4 quarters
IDN icon
21
Intellicheck
IDN
$38M
$5.22M 1.09%
2,073,583
– –
2019 Q4
11 quarters
DUOT icon
22
Duos Technologies
DUOT
$158M
$5.21M 1.09%
1,283,162
– –
2020 Q1
10 quarters
MIST icon
23
Milestone Pharmaceuticals
MIST
$64.7M
$4.71M 0.98%
512,500
– –
2021 Q4
3 quarters
AENT icon
24
Alliance Entertainment
AENT
$252M
$3.98M 0.83%
400,000
– –
2021 Q2
5 quarters
LSXMA icon
25
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
$3.94M 0.82%
141,002
– –
2020 Q2
9 quarters

Similar funds

Bleichroeder's Q3 2022 Portfolio in Review

As of Q3 2022, Bleichroeder held 98 positions worth $479M, down 1% from $484M the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Bleichroeder's Q3 2022 filing shows 1 new, 4 increased, 1 reduced and 5 closed positions. Its largest new stake was ProKidney: 2,000,000 shares worth $18M. The largest sale was Isleworth Healthcare Acquisition Corporation Common stock, an estimated $10M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Miscellaneous.

  • Bleichroeder's largest Q3 2022 buy was ProKidney: 2,000,000 shares worth $18M.
  • Bleichroeder added most to GPGI Inc in Q3 2022, an estimated $3.2M increase.
  • Bleichroeder's biggest Q3 2022 reduction was CTI BioPharma Corp. (DE) Common Stock, cutting an estimated $31.2K.
  • Bleichroeder fully exited Isleworth Healthcare Acquisition Corporation Common stock in Q3 2022, selling an estimated $10M.
  • Bleichroeder's ten largest holdings make up 67% of its $479M portfolio in Q3 2022.
  • Bleichroeder opened 1 new position and closed 5 in Q3 2022.
  • Bleichroeder's portfolio value fell 1% quarter-over-quarter to $479M.

Based on Bleichroeder's 13F filing for Q3 2022, filed 14 Nov 2022.